Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Didanosine vs Zidovudine in HIV Patients on Long-Term Zidovudine
NCT00000671Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Primary completion
- Mar 1992
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of didanosine in human immunodeficiency virus infection (HIV), sponsored by National Institute of Allergy and Infectious Diseases. Status: completed.
02
Drugs
didanosine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00000671.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000671.